Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001999371-25-003885
Filing Date
2025-04-07
Accepted
2025-04-07 09:13:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL DEFINITIVE PROXY MATERIAL opus-defa14a_040725.htm DEFA14A 51749
  Complete submission text file 0001999371-25-003885.txt   53069
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27709
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27709 248-681-9815
Opus Genetics, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34079 | Film No.: 25816536
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)